#pfizer-vaccine

#pfizer-vaccine

After hours of deliberation over safety concerns, a Food and Drug Administration advisory panel on Wednesday recommended approval of a second vaccine for the respiratory syncytial virus in older adults, advancing the first shots against an illness that can be deadly for the very young and the very old.

The Food and Drug Administration on Wednesday approved GSK's vaccine for the respiratory syncytial virus, or R.S.V., for adults who are 60 and older, the company said.The vaccine, to be sold as Arexvy, appears to be the first in the world approved for sale to protect older adults.Image An transmission electron microscopic image of R.S.V.Credit...Centers for Disease Control and Prevention The F.D.A. estimates that R.S.V. is associated with 6,000 to 10,000 deaths each year in adults 65 and older and at least 60,000 hospitalizations in that age group.

Last week, the US Food and Drug Administration authorized the bivalent Covid-19 booster for children 6 months to 5 years old.The US Centers for Disease Control and Prevention has since recommended the booster, and now everyone 6 months and older is able to receive the updated coronavirus vaccine except kids who got three doses produced by Pfizer/BioNTech.

A nurse manager who has been given just months to live says bungling medics dismissed her cancer symptoms as side-effects of having the Covid jab.Katie Pritchard, 37, is having to crowdfund 200,000 for private treatment after she was twice misdiagnosed before finding out she had cervical cancer.The mother-of-two went to her GP after finding a lump but was told there was nothing to worry about and her symptoms may have been down to the Pfizer vaccine.

Private services offering Chinese travellers access to mRNA vaccines are attracting droves of mainlanders to Hong Kong and Macau seeking a booster shot that their government has refused to approve.As part of its dismantling of the country's zero-Covid policy last month, China's government also lifted quarantine and other border restrictions.

The other week in China's Xinjiang, a fire flared up and killed 10 people in an apartment building.Questions over the need for an ongoing lockdown transformed into a full-on protest.People demanded that the government end the zero-COVID policy.It's not just that it's hard to live in continual lockdown.

A patient is turned away from the emergency room due to full capacity at the Baoding No. 2 Central Hospital in Zhuozhou city in northern China's Hebei province on Wednesday, Dec. 21, 2022.China only counts deaths from pneumonia or respiratory failure in its official COVID-19 death toll, a Chinese health official said, in a narrow definition that limits the number of deaths reported, as an outbreak of the virus surges following the easing of pandemic-related restrictions.